Nextgen (NXGN) - Net Assets
Based on the latest financial reports, Nextgen (NXGN) has net assets worth ILA-9.72 Million ILA (≈ $-26.05K USD) as of June 2025. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (ILA1.48 Million ≈ $3.97K USD) and total liabilities (ILA11.20 Million ≈ $30.02K USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check Nextgen (NXGN) asset resilience to evaluate the company's liquid asset resilience ratio.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | ILA-9.72 Million |
| % of Total Assets | -656.04% |
| Annual Growth Rate | N/A |
| 5-Year Change | -135.89% |
| 10-Year Change | -242.07% |
| Growth Volatility | 190.74 |
Nextgen - Net Assets Trend (2008–2024)
This chart illustrates how Nextgen's net assets have evolved over time, based on quarterly financial data. Also explore NXGN current and non-current assets for the complete picture of this company's asset base.
Annual Net Assets for Nextgen (2008–2024)
The table below shows the annual net assets of Nextgen from 2008 to 2024. For live valuation and market cap data, see Nextgen (NXGN) market capitalisation.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | ILA-2.46 Million ≈ $-6.61K |
-151.79% |
| 2023-12-31 | ILA-979.00K ≈ $-2.62K |
-107.99% |
| 2022-12-31 | ILA12.25 Million ≈ $32.84K |
-40.84% |
| 2021-12-31 | ILA20.71 Million ≈ $55.51K |
+201.49% |
| 2020-12-31 | ILA6.87 Million ≈ $18.41K |
+486.01% |
| 2019-12-31 | ILA1.17 Million ≈ $3.14K |
-50.92% |
| 2018-12-31 | ILA2.39 Million ≈ $6.40K |
-34.72% |
| 2017-12-31 | ILA3.66 Million ≈ $9.81K |
-28.74% |
| 2016-12-31 | ILA5.13 Million ≈ $13.76K |
+195.85% |
| 2015-12-31 | ILA1.74 Million ≈ $4.65K |
+296.27% |
| 2014-12-31 | ILA-884.00K ≈ $-2.37K |
-358.48% |
| 2013-12-31 | ILA342.00K ≈ $916.89 |
-85.71% |
| 2012-12-31 | ILA2.39 Million ≈ $6.42K |
-13.20% |
| 2011-12-31 | ILA2.76 Million ≈ $7.39K |
-59.93% |
| 2010-12-31 | ILA6.88 Million ≈ $18.45K |
+43.39% |
| 2008-12-31 | ILA4.80 Million ≈ $12.86K |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Nextgen's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 7094200000.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Other Components | ILA68.60 Million | % |
| Total Equity | ILA-2.34 Million | 100.00% |
Nextgen Competitors by Market Cap
The table below lists competitors of Nextgen ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Ngenic AB
ST:NGENIC
|
$1.53 Million |
|
GGX Gold Corp
V:GGX
|
$1.53 Million |
|
GEMINA LABS LTD
F:8I7
|
$1.53 Million |
|
CanadaBis Capital Inc
V:CANB
|
$1.53 Million |
|
CBEYOND
F:C5B
|
$1.52 Million |
|
Pineapple Financial Inc.
NYSE:PAPL
|
$1.52 Million |
|
Im Cannabis Corp
NASDAQ:IMCC
|
$1.52 Million |
|
Creative Eye Limited
NSE:CREATIVEYE
|
$1.52 Million |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Nextgen's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -860,000 to -2,341,000, a change of -1,481,000.
- Net loss of 4,892,000 reduced equity.
- New share issuances of 2,140,000 increased equity.
- Other comprehensive income decreased equity by 7,036,000.
- Other factors increased equity by 8,307,000.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | ILA-4.89 Million | -208.97% |
| Share Issuances | ILA2.14 Million | +91.41% |
| Other Comprehensive Income | ILA-7.04 Million | -300.56% |
| Other Changes | ILA8.31 Million | +354.85% |
| Total Change | ILA- | % |
Book Value vs Market Value Analysis
This analysis compares Nextgen's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2013-12-31 | ILA0.13 | ILA52.20 | x |
| 2014-12-31 | ILA-0.24 | ILA52.20 | x |
| 2015-12-31 | ILA0.24 | ILA52.20 | x |
| 2016-12-31 | ILA0.27 | ILA52.20 | x |
| 2017-12-31 | ILA0.13 | ILA52.20 | x |
| 2018-12-31 | ILA0.09 | ILA52.20 | x |
| 2019-12-31 | ILA0.04 | ILA52.20 | x |
| 2020-12-31 | ILA0.21 | ILA52.20 | x |
| 2021-12-31 | ILA0.52 | ILA52.20 | x |
| 2022-12-31 | ILA0.29 | ILA52.20 | x |
| 2023-12-31 | ILA-0.12 | ILA52.20 | x |
| 2024-12-31 | ILA-0.28 | ILA52.20 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Nextgen utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 0.00%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 0.00x
- Recent ROE (0.00%) is above the historical average (-229.28%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2013 | -2191.20% | 0.00% | 0.00x | 3.67x | ILA-8.25 Million |
| 2014 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-4.85 Million |
| 2015 | -238.95% | 0.00% | 0.00x | 1.36x | ILA-4.51 Million |
| 2016 | -34.64% | 0.00% | 0.00x | 1.15x | ILA-2.33 Million |
| 2017 | -39.98% | 0.00% | 0.00x | 1.16x | ILA-1.87 Million |
| 2018 | -50.87% | 0.00% | 0.00x | 1.25x | ILA-1.51 Million |
| 2019 | -95.52% | 0.00% | 0.00x | 1.52x | ILA-1.34 Million |
| 2020 | -18.60% | 0.00% | 0.00x | 1.19x | ILA-1.99 Million |
| 2021 | -12.25% | 0.00% | 0.00x | 1.14x | ILA-4.63 Million |
| 2022 | -69.35% | 0.00% | 0.00x | 1.20x | ILA-9.81 Million |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-14.11 Million |
| 2024 | 0.00% | 0.00% | 0.00x | 0.00x | ILA-4.66 Million |
Industry Comparison
This section compares Nextgen's net assets metrics with peer companies in the Medical Instruments & Supplies industry.
Industry Context
- Industry: Medical Instruments & Supplies
- Average net assets among peers: $80,869,667
- Average return on equity (ROE) among peers: 12.06%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Nextgen (NXGN) | ILA-9.72 Million | -2191.20% | N/A | $1.53 Million |
| Batm Advanced Communications Ltd (BVC) | $114.00 Million | 0.21% | 0.54x | $51.06 Million |
| Nissan (NISA) | $129.84 Million | 35.97% | 2.73x | $19.06 Million |
| Storage Drop Storage Technologies Ltd (STRG) | $-1.23 Million | 0.00% | 0.00x | $614.25K |
About Nextgen
Nextgen Biomed Ltd develops topical treatment for psoriasis. The company was formerly known as Sela Group.Com Ltd. and changed its name to Nextgen Biomed Ltd in February 2010. Nextgen Biomed Ltd was incorporated in 1990 and is based in Tel Aviv, Israel.